Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study

Our previous phase I/IIA study showed that autologous dendritic cells (DCs) pulsed with tumor-associated antigens are well tolerated in patients with hepatocellular carcinoma (HCC). In this randomized, multicenter, open-label, phase II trial, we investigated the efficacy and safety of this DC-based...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncoimmunology
Auteurs principaux: Lee, Jeong-Hoon, Tak, Won Young, Lee, Yoon, Heo, Min-Kyu, Song, Jae-Sung, Kim, Hak-Yeop, Park, Soo Young, Bae, Si Hyun, Lee, Joon Hyeok, Heo, Jeong, Kim, Ki-Hwan, Bae, Yong-Soo, Kim, Yoon Jun
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2017
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5543846/
https://ncbi.nlm.nih.gov/pubmed/28811965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1328335
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires